Researchers at Duke University developing a glioblastoma treatment based on poliovirus are unraveling the process by which the virus fights malignancy.
Researchers at Sanofi and the NIH have published preclinical evidence showing that a three-pronged approach may prevent HIV in healthy people.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
The past week's research news included developments in pediatric brain tumors, asthma and KRAS-mutant cancers.
Researchers at the University of Montreal Hospital Research Centre say they’ve discovered a way to block the replication of HIV in viral reservoirs.
Australian scientists have found a natural compound in seaweed that can halt inflammation after traumatic brain injury.
A research team led by the University of Chicago has discovered that lymphatic vessels can enable immune cells to kill cancer cells.
Researchers at Massachusetts Eye and Ear have found a group of blood-based biomarkers that could improve diagnosis and treatment for AMD.
Bristol-Myers is moving a new med that targets LAG-3 into late-stage testing as an add-on to Opdivo for resistant melanoma patients.
The past week brought news of discoveries in neuroblastoma, type 1 diabetes and multiple sclerosis.
Researchers have developed two experimental compounds inspired by the fire ant that appear promising in treating psoriasis.